Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
6.9 USD | -0.58% | -11.87% | +36.06% |
05-09 | ImmunityBio, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
05-07 | ImmunityBio Shares Rise After Completion of Drug Substance Manufacturing for Cancer Treatment | MT |
This article is reserved for subscribers
Signed up already?
Log InNot subscribed yet?
SubscribeEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+36.06% | 4.8B | |
+10.41% | 115B | |
+12.76% | 106B | |
-4.27% | 24.69B | |
-2.47% | 21.97B | |
-6.03% | 19.27B | |
-11.60% | 17.56B | |
-39.36% | 17.32B | |
+6.18% | 14.03B | |
+32.25% | 12.13B |
- Stock Market
- Equities
- IBRX Stock
- News ImmunityBio, Inc.
- Transcript : NantKwest, Inc. - Special Call